If you missed the unique Dermoscopy Masterclass taught by Professors Harald Kittler, Iris Zalaudek and Cliff Rosendahl during the 2017 Skin Cancer Summit, don't miss the opportunity to purchase a recording now. The learning outcomes will change the way you work forever to the benefit of your job satisfaction and the well-being of your patients.
MASTERCLASS "DIAGNOSIS AND DERMOSCOPY"
Taught by three pioneers in the Dermoscopy field, the masterclass covers pattern analysis, treatment of Melanoma, epithelial proliferations, revision and update on special sites, and the importance of dermatoscopic-pathologic correlation. You will gain valuable insights on on the following topics:
Diagnosis and treatment of high-risk BCC
Clinical characteristics and current treatment options of BCC and how we can reduce the morbidity from this type of cancer. Even though it rarely metastasises it can cause local destruction of underlying tissues.
Dermoscopic classification of melanocytic nevi
Review of the dermoscopic classification of melanocytic nevus which embraces a spectrum of different benign melanocytic proliferations that differ with respect to their epidemiology, morphology, growth dynamics, and associated melanoma risk.
Management of epithelial proliferations
New dermoscopic criteria associated with NMSC which have been introduced during the past five years, and aid in the diagnosis and management decision of these tumours.
Decision making with Dermoscopy
Dermoscopy in the diagnosis of tumoural and non-tumoral skin lesions, and as a tool to decide on the most appropriate treatment of skin tumours as well as in the post-treatment monitoring of response.
Multiple nevi and the risk of melanoma
Review of two highly valuable approaches – the comparative approach and digital monitoring – in the management of patients with multiple nevi in order to improve early diagnosis of melanoma and reduce the number of unnecessary excisions of benign nevi.
Diagnosis and treatment of Actinic Keratosis
Dermoscopic criteria of this most common form of skin cancer which aids the diagnosis and the response to treatment.
DERMOSCOPY MASTERCLASS PRESENTERS
|Harald Kittler, Professor at the Department of Dermatology, Medical University of Vienna. Harald has special clinical interest in dermoscopy of pigmented skin lesions. The main research interest is digital dermoscopy, follow-up of pigmented skin lesions and computer assisted digital dermoscopy. Harald is a member of the American Academy of Dermatology, The International Society of Dermatopathology, The International Society of Dermoscopy, The Skin Cancer College of Australia and New Zealand, and the European Society of Dermatology and Venereology. He has published over 80 manuscripts in peer-reviewed journals and presented at over 50 invited international lectures in Australia, Europe and USA.|
|Iris Zalaudek, Research Director of the Non-Melanoma Skin Cancer Unit, Division of Dermatology and Venerology, Medical University of Graz. Iris's main research fields are dermato-oncology and in particular, dermoscopy, nevogenesis, melanoma and non-melanoma skin cancer. She has authored more than 150 scientific articles in international peer-review journals. Her combined publications have received an h-index value of 20 (November 2011). In 2003 her work was awarded by the Hans-Weitgasser Price from the Styrian Association of Dermatologists and in 2008 she was awarded the Best Researcher of the Medical University of Graz, Austria.|
|Cliff Rosendahl currently works in Brisbane, Australia as a primary care practitioner with a special interest in skin cancer. He also has an interest in research as the clinical developer and Director of the Skin Cancer Audit Research Database (SCARD). His other main area of research has been in evaluating dermatoscopic clues for the diagnosis of both pigmented and non-pigmented skin malignancy in collaboration with colleagues at The University of Queensland, Australia and the Medical University of Vienna, Austria. Cliff has a strong commitment to teaching with a view to achieving an improvement in both the detection and management of skin cancer in Australasia and internationally.|